News

Aarti Drugs Limited will hold a board meeting on Thursday, August 27, 2026, to consider and approve the “Aarti Drugs Limited – Performance Stock Option Plan 2026,” and the trading window for the company will be closed from August 25, 2026, until August 29, 2026, in accordance with SEBI regulations.

Net profit of Aarti Drugs declined 6.94% to Rs 50.17 crore in the quarter ended June 2026 as against Rs 53.91 crore during the previous quarter ended June 2025. Sales rose 19.01% to Rs 702.78 crore in the quarter ended June 2026 as against Rs 590.51 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales702.78590.51 19 OPM %13.9712.55 - PBDT89.7965.83 36 PBT71.3351.11 40 NP50.1753.91 -7 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 31 July 2026.

Net profit of Aarti Drugs declined 12.20% to Rs 55.19 crore in the quarter ended March 2026 as against Rs 62.86 crore during the previous quarter ended March 2025. Sales rose 6.43% to Rs 720.30 crore in the quarter ended March 2026 as against Rs 676.76 crore during the previous quarter ended March 2025.For the full year,net profit rose 15.91% to Rs 194.92 crore in the year ended March 2026 as against Rs 168.16 crore during the previous year ended March 2025. Sales rose 7.47% to Rs 2565.31 crore in the year ended March 2026 as against Rs 2387.03 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales720.30676.76 6 2565.312387.03 7 OPM %13.3013.79 -12.0512.03 - PBDT88.4086.04 3 277.87267.55 4 PBT70.3671.16 -1 210.90211.77 0 NP55.1962.86 -12 194.92168.16 16 Powered by Capital Market - Live News

Net profit of Aarti Drugs declined 26.87% to Rs 44.96 crore in the quarter ended March 2026 as against Rs 61.48 crore during the previous quarter ended March 2025. Sales rose 1.40% to Rs 631.68 crore in the quarter ended March 2026 as against Rs 622.96 crore during the previous quarter ended March 2025.For the full year,net profit rose 7.57% to Rs 169.22 crore in the year ended March 2026 as against Rs 157.31 crore during the previous year ended March 2025. Sales rose 3.99% to Rs 2260.39 crore in the year ended March 2026 as against Rs 2173.65 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales631.68622.96 1 2260.392173.65 4 OPM %12.5514.23 -11.5412.08 - PBDT73.5282.88 -11 236.95246.54 -4 PBT58.5770.67 -17 181.31198.75 -9 NP44.9661.48 -27 169.22157.31 8 Powered by Capital Market - Live News